Minimal/Measurable Residual Disease - The Bloodline with Blood Cancer United Podcast

The Revolution of Genomics: How Testing Leads to Individualized Treatment

Listen Later

Have you ever wondered how doctors determine the treatment for a blood cancer patient? In this episode, we’re speaking with Dr. Eric Severson of Labcorp Oncology and Dr. John DiPersio of Washington University in St. Louis, MO, about genomics testing, what it is, and how it benefits blood cancer patients. You will learn about the crucial collaboration between pathologists and oncologists to make sure patients are getting the most accurate diagnosis and best possible treatments for their particular blood cancers.

DOWNLOAD TRANSCRIPT
CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

  • Genomics Testing Video
  • Genomics Tests (FISH, Flow Cytometry, Next-generation Sequencing)
  • Acute Myeloid Leukemia
  • Minimal/Measurable Residual Disease
  • A Medication Resource for Blood Cancer Patients
  • Minimal/Measurable Residual Disease Chart 
  • CAR T-cell Therapy
  • Stem Cell Transplantation
  • Beat AML Master Clinical Trial
  • Dare To Dream

    • Additional LLS Support Resources: 

    • Information Specialists 
    • Free telephone/web patient programs 
    • Free booklets 
    • Clinical Trial Support Center
    • Financial support
    • Young Adult Resources
    • Caregiver support 
    • Caregiver Workbook
    • Survivorship Workbook
    • Online chats 
    • LLS Community 
    • Support groups 
    • Patti Robinson Kaufmann First Connection Program 
    • Free Nutrition Consultations

      • Support for this episode provided by: Labcorp Oncology.

      The post The Revolution of Genomics: How Testing Leads to Individualized Treatment first appeared on The Bloodline with Blood Cancer United Podcast.

      ...more
      View all episodesView all episodes
      Download on the App Store
      Minimal/Measurable Residual Disease - The Bloodline with Blood Cancer United PodcastBy Blood Cancer United